Maxim Biotech, Inc. was founded in July 1992 in the state of California. Maxima's principle objective is to employ biological processes to develop quality and innovative products for health care and life science. The company brings substantial value to the market by improving the manner in which life science and medical researchers perform nucleic acid amplification assays. Nucleic acid amplification is the cornerstone of genome analysis and is a time consuming, laborious process.